US Patent No. 8,076,290 regarding stabilized formulations of parathyroid hormone (PTH) and PTH peptide analogs for various means of delivery, including intranasal delivery, has been awarded to Aegis Therapeutics. PTH and PTH peptide analogs such as PTH 1-34 (teriparatide) are used for the treatment of osteoporosis. Aegis has licensed the patent exclusively to Azelon … [Read more...] about Aegis gets patent for osteoporosis drug formulations
News
FDA committee recommends approval of Adasuve inhaled loxapine
After meeting to discuss concerns about the safety of Alexza Pharmaceutical's Adasuve Staccato loxapine, the FDA's Psychopharmacologic Drugs Advisory Committee voted 9 to 8, with 1 abstention, to recommend approval for a single dose in 24 hours when used with the FDA-recommended Risk Evaluation and Mitigation Strategy (REMS), for the treatment for agitation in … [Read more...] about FDA committee recommends approval of Adasuve inhaled loxapine
Intranasal norovirus vaccine capable of reducing infection
An article published in the December 8, 2011 issue of the New England Journal of Medicine describes a proof of principle study in which an intranasal dry powder vaccine significantly reduced Norwalk virus gastroenteritis and infection in study participants innoculated with Norwalk virus. LigoCyte Pharmaceuticals created the vaccine from virus-like particles since … [Read more...] about Intranasal norovirus vaccine capable of reducing infection
John Thievon named President of Dey Pharma
Mylan has appointed John Thievon as president of its subsidiary Dey Pharma, whose products include Perforomist formoterol inhalation solution and the EasyVent valved holding chamber for MDIs. Thievon was most recently President and CEO of Middlebrook Pharmaceuticals and was previously Executive VP of Commercial Operations at Adams Respiratory Therapeutics. "I am … [Read more...] about John Thievon named President of Dey Pharma
FDA committee to discuss safety of Adasuve loxapine inhalation powder
The US FDA has announced a December 12 meeting of the Psychopharmacologic Drugs Advisory Committee to discuss safety concerns related to Alexza's Adasuve loxapine inhalation powder for the treatment of agitation associated with schizophrenia or bipolar disorder. Alexza resubmitted an NDA for the product in August 2011. The company first submitted the NDA in December … [Read more...] about FDA committee to discuss safety of Adasuve loxapine inhalation powder
Aradigm gets patents for inhaled ciprofloxacin formulations, announces plans for Pulmaquin Phase 3 trials
The United States Patent and Trademark Office has issued US Patent No. 8,071,127 regarding formulations of inhaled liposomal and free ciprofloxacin to Aradigm Corporation. The patent covers the company's lead candidate, Pulmaquin dual release ciprofloxacin for inhalation, and should provide exclusivity for the product until October 22, 2027. Aradigm now plans to take … [Read more...] about Aradigm gets patents for inhaled ciprofloxacin formulations, announces plans for Pulmaquin Phase 3 trials
Decision Resources predicts flat asthma drug market through 2020
A report from research firm Decision Resources predicts no growth in the asthma drug market through 2020, in large part due to incursions by generics and greater competition. According to the company, "The overall asthma drug market will decrease slightly from $14.6 billion in 2010 to $14.4 billion in 2020 in the United States, France, Germany, Italy, Spain, the … [Read more...] about Decision Resources predicts flat asthma drug market through 2020
NanoBio to collaborate with Merck on intranasal RSV vaccine
Merck and NanoBio will conduct preclinical studies to evaluate a vaccine combining Merck's respiratory syncyctial virus (RSV) antigen with NanoBio's NanoStat adjuvant. NanoBio has already conducted studies that showed the induction of immunity by a NanoStat-adjuvanted RSV vaccine "without eliciting the enhanced respiratory disease that has caused other RSV vaccine … [Read more...] about NanoBio to collaborate with Merck on intranasal RSV vaccine
Powder Flow 2011 poster prize awarded to Hanne Kinnunen
The prize for the best poster presented at PowderFlow 2011 was awarded to Hanne Kinnunen, a PhD student in the Pharmaceutical Surface Science Research Group, Department of Pharmacy and Pharmacology at the University of Bath, for her poster titled, "The impact of loaded drug dose and the surface roughness of the coarse lactose carrier to the fluidisation … [Read more...] about Powder Flow 2011 poster prize awarded to Hanne Kinnunen
Aptar introduces new metering valve at DDL 22
Aptar Pharma launched its new DF30Plus metering valve, an extension of its DF30 line, at DDL 22. According to the company, the new valve is more compatible with a wide range of formulations, including those containing ethanol, and also has "ultra-low extractable levels" and "excellent pressure filling capability." Aptar Pharma Prescription Division's Associate … [Read more...] about Aptar introduces new metering valve at DDL 22